News Detail
New Delhi, 15 July 2024: Pharmaceutical companies will be allowed to escape legal proceedings for violations of the Drugs and Cosmetics Act, and settle matters out of court under draft rules that have been framed by the Central government.
Under these rules, to be noti......
View Details
Source : Livemint
pharmaceutical
Drugs and Cosmetics Act
government of India
legal proceedings
draft rules
Jan Vishwas Act 2023
Related News
- Critical medicines for cancer, diabetes set to get expensive as govt clears price hike, say sources (27-03-2025)
- DGFT proposes mandatory GST E-Invoices for pharma export benefits (27-03-2025)
- US FDA approves first treatment for rare genetic disorder Prader-Willi syndrome (27-03-2025)
- FDA approves GSK’s 'Blujepa' for uncomplicated UTIs (27-03-2025)
- Bengal drug control publishes helpline to report fake medicines (27-03-2025)
- Misleading ads: SC asks states UTs to set up grievance redressal mechanism (26-03-2025)
- WHO partners with regulators, experts to strengthen safety and access of medical devices (26-03-2025)
- PCI warns of tough action against inspectors who don't follow its guidelines during inspection (26-03-2025)
- Seizure of fake Human Albumin Vials rings alarm bells (26-03-2025)
- Pharmacy owner, three others held for illegal sale of intoxication drug (26-03-2025)